LONDON: A “variant-proof” vaccine produced in Britain has received millions in funding in the hope that it can defeat COVID-19 and future coronaviruses.
Prime Minister Boris Johnson praised the technological breakthrough posed by the vaccine, which he said is part of the “next generation of vaccines” while opening a conference for the Coalition for Epidemic Preparedness Innovations.
The coalition is set to donate some £32 million ($42 million) to support the production of the vaccine, which is being made by Diosynvax, an organization born out of Cambridge University.
The new vaccine is one of several hopeful inoculation projects that are aimed at targeting parts of the virus that are less likely to mutate, making…